Aurigon Life Science GmbH

Where the EU money came from

Funding by EU programme. Amounts are Aurigon Life Science GmbH's own share of each project, not the project's full budget.

Projects

2 EU-funded projects, newest first. Each links to the official record.

• HCV NEW INHIBITORSPartner

  HCV Progress in Therapy with Novel Sialomimetic-chimeric inhibitors

  FP7 (2007 to 2013) · 2013–2015 · Project on CORDIS ↗

  €13ktheir share
• CORLINEPartner

  Corline Heparin Technology - Enabling Regenerative Medicine

  FP7 (2007 to 2013) · 2011–2013 · Project on CORDIS ↗

  €3ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Vrije Universiteit BrusselBelgium · 1 shared project
• University of LeedsUnited Kingdom · 1 shared project
• Medizinische Hochschule HannoverGermany · 1 shared project
• Universita Degli Studi del Piemonte Orientale Amedeo AvogadroItaly · 1 shared project
• Region UppsalaSweden · 1 shared project
• Corline Biomedical ABSweden · 1 shared project
• Beta-CellBelgium · 1 shared project
• Cyathus Exquirere PharmaforschungsgmbhAustria · 1 shared project
• 3s Pharmacological Consultation & Res.srlRomania · 1 shared project
• TherapiconItaly · 1 shared project
• Tissue Regenix LimitedUnited Kingdom · 1 shared project
• Institutul National de Cercetare Dezvoltare Chimico Farmaceutica Iccf BucurestiRomania · 1 shared project
• Nordicblue ABSweden · 1 shared project
• Cytonet GmbH & Co. KGGermany · 1 shared project
• Duke Chem SASpain · 1 shared project
• Pharma Serv International SRLRomania · 1 shared project

Fields it works in

Research fields recorded on its Horizon projects.

• carbohydrates
• cells technologies
• diabetes
• hepatitis C
• hepatology
• integrative and complementary medicine
• oncology
• tissue engineering
• transplantation
• vaccines